Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects
Recent Articles How to Reflect Your Practice Philosophy Online Healthcare practitioners often see how their practice philosophy shapes every patient interaction
The timelines here come from preclinical (mostly rodent) studies and clinical-practice observation, and they are ranges, not promises
Despite the weak clinical evidence, there are scenarios where AOD 9604 might make sense as part of a fat loss strategy
learn more MIC stands for Methionine, Inositol, and Cholinethree lipotropic agents that help break down fat and support liver function
Sikiric, P., Seiwerth, S., Grabarevic, Z., Rucman, R., Petek, M., Jagic, V., Turkovic, B., Rotkvic, I., Mise, S., Zoricic, I., Konjevoda, P., Perovic, D., Simicevic, V., Separovic, J., Hanzevacki, M., Ljubanovic, D., Artukovic, B., Bratulic, M., Tisljar, M., & Rekic, B